Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Summary of clinical experiences with tamsulosin for the treatment of benign prostatic hyperplasia.

Summary of clinical experiences with tamsulosin for the treatment of benign prostatic hyperplasia. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Summary of clinical experiences with tamsulosin for the treatment of benign prostatic hyperplasia. Abstract Text:

    franklin c loweFranklin C Lowe,

    Tamsulosin, a uroselective alpha(1A)-adrenergic-receptor antagonist, has been shown to improve lower urinary tract symptoms associated with benign prostatic hyperplasia. It has a better side effect profile than earlier alpha-adrenergic-receptor antagonists, which were initially developed as antihypertensive agents. Clinical trials of 1 year or longer with tamsulosin show high tolerability for the 0.4 mg dose and no significant interaction with other antihypertensive medications.

    Summary of clinical experiences with tamsulosin for the treatment of benign prostatic hyperplasia. Publishing Authors By Initials

    fc loweFC Lowe,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Summary of clinical experiences with tamsulosin for the treatment of benign prostatic hyperplasia. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Reviews in urology

    VOLUME: 7 Suppl 4

    Page Numbers: S13-21

    Journal Abbreviation:

    ISSN: 1523-6161

    DAY: 20

    MONTH: 09

    YEAR: 2005

    Summary of clinical experiences with tamsulosin for the treatment of benign prostatic hyperplasia. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 100889067

    Summary of clinical experiences with tamsulosin for the treatment of benign prostatic hyperplasia. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Summary of clinical experiences with tamsulosin for the treatment of benign prostatic hyperplasia. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Summary of clinical experiences with tamsulosin for the treatment of benign prostatic hyperplasia.

    AFFILIATION:

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Rev Urol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Summary of clinical experiences with tamsulosin for the treatment of benign prostatic hyperplasia Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News